A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 26, Issue 2, 2012, Pages 111-114

  Lyckholm, Laurel ^a   Heddinger, Steven P ^b   Parker, Gwendolyn ^a   Coyne, Patrick J ^a   Ramakrishnan, Viswanathan ^c   Smith, Thomas J ^d   Henkin, Robert I ^e  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b Medical Oncology and Hematology Associates   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e Taste and Smell Clinic   (United States)

Author keywords

Cancer; Chemotherapy; Smell; Taste; Zinc

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CAPECITABINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; IDARUBICIN; IFOSFAMIDE; IRINOTECAN; MITOXANTRONE; NAVELBINE; OXALIPLATIN; PACLITAXEL; PLACEBO; RITUXIMAB; TRASTUZUMAB; VINCRISTINE; ZINC;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; HEAD AND NECK CANCER; HEAD INJURY; HUMAN; LIVER DISEASE; MALE; NEOPLASM; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SMELLING DISORDER; TASTE DISORDER; WELLBEING;

ANTINEOPLASTIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OLFACTION DISORDERS; TASTE DISORDERS; TIME FACTORS; TREATMENT OUTCOME; ZINC SULFATE;

EID: 84863596829     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.3109/15360288.2012.676618     Document Type: Article

References (10)

1. Halyard MY. Taste and smell alterations in cancer patients-Real problems with few solutions. J Support Oncol. 2009;7:68-69.
2. Hong JH, Omur-Ozbek P, Stanek BT, et al. Taste and odor abnormalities in cancer patients. J Support Oncol. 2009; 7:58-65.
3. Henkin RI. Taste and smell disorders, human. In: ADELMAN G, Smith BH, eds. Encyclopedia of Neuroscience. 3rd ed. Amsterdam: ELSEVIER; 2004:2010-2013.
4. Henkin Ri, Martin BM, Ararwal RP. Decreased parotid saliva gustin/carbonic anhydrase VI secretion: An enzyme disorder manifested by gustatory and olfactory dysfuction. Am J Med Sci. 1999;318:380-391.
5. Henkin RI, Martin BM, Agarwal, RP. Efficacy of exogenous zinc in treatment of patients with carbonic anhydrase VI deficiency. Am J Med Sci. 1999;318:392-404.
6. Yamagata T, Nakamura Y, Yamagata Y, et al. The pilot trial of the prevention of the increase in electrical taste thresholds by zinc containing fluid infusion during chemotherapy to treat primary lung cancer. J Exp Clin Cancer Res. 2003;22:557-563.
7. Henkin RI, Schechter PJ, Friedewald WT, et al. A double blind study of the effects of zinc sulfate on taste and smell dysfunction. Am J Med Sci. 1976;272:285-299.
8. Wickham RS, Rehwaldt M, Kefer C, et al. Taste changes experienced by patients receiving chemotherapy. Oncol Nurs Forum. 1999;26:697-706.
9. Halyard MY, Jatoi A, Sloan JA, et al. Does zinc sulfate prevent therapy-Induced taste alterations in head and neck cancer patients? Results of phase III double blind, placebo-Controlled trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys. 2007;67:1318-1322.
10. Ripamonti C, Zecca E, Brunelli C, et al. A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Cancer. 1998;82:1938-1945.